Cytokinetics | CYTK - Current Liabilities



Cytokinetics reported $131.06M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Acadia Pharmaceuticals USD 330.02M 27.49M Jun/2025
Amgen USD 20.48B 2.53B Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Cytokinetics USD 131.06M 28.66M Jun/2025
Eisai JPY 411.61B 39.31B Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Exelixis USD 336.11M 62.99M Jul/2025
Geron USD 64.28M 1.25M Jun/2025
Halozyme Therapeutics USD 134.28M 16.1M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Ligand Pharmaceuticals USD 64.73M 6.05M Jun/2025
Merck USD 26.04B 863M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025